RESULTS Sixty-six patients with CMI and 41 with IIH were identified, with comparable demographics noted in both groups. The occurrence of some symptoms (headache, nausea, and/or vomiting) was comparable between the cohorts. Dizziness and gait ataxia were significantly more common in patients with CMI, whereas visual symptoms, diplopia, and tinnitus were significantly more frequent in patients with IIH. The cranial volume measurements (VV, PCFV, and ICV) of the CMI and IIH patients were similar. Notably, 7.3% of the IIH patients had tonsillar descent qualifying for diagnosis of CMI (that is, > 5 mm). The extent of tonsillar ectopy was significantly different between the CMI and IIH cohorts (p < 0.001) but also between these 2 cohorts and the REF group. Pulsatile ICP was elevated in both cohorts without any significant between-group differences; however, static ICP was significantly higher (p < 0.001) in the IIH group. CONCLUSIONS This study showed comparable and elevated pulsatile ICP, indicative of impaired intracranial compliance, in both CMI and IIH cohorts, while static ICP was higher in the IIH cohort. The data did not support the hypothesis that reduced PCFV combined with increased ICP causes tonsillar ectopy in CMI. Even though impaired intracranial compliance seems to be a common pathophysiological mechanism behind both conditions, the mechanisms explaining the different clinical and radiological presentations of CMI and IIH remain undefined. 
C hiari malformation Type I (CMI) and idiopathic intracranial hypertension (IIH), also referred to as a subset of the primary pseudotumor cerebri syndrome, 22 are established clinical entities often encountered by neurologists and neurosurgeons. Chiari malformation Type I is primarily characterized by idiopathic ectopy of the cerebellar tonsils, often syringomyelia, and occasionally anomalies of the posterior cranial fossa (PCF) and the craniocervical junction, and patients present with a broad spectrum of clinical symptoms. 33 The tentative treatment for symptomatic CMI is foramen magnum decompression (FMD). 5, 28, 41 Patients with IIH typically present with headache and visual disturbances, with evidence of papilledema and high opening pressure on lumbar puncture. These symptoms occur despite the absence of radiological evidence of hydrocephalus, a negative neurological examination except for cranial nerve abnormalities, and a normal cerebrospinal fluid (CSF) composition. 9, 22 The treatment options in IIH are repeated lumbar tapping, weight reduction, acetazolamide, and surgical diversion of the CSF (that is, shunt surgery) or optic nerve sheath fenestration. 8, 36 The pathophysiological mechanisms behind CMI and IIH are still poorly understood, and current treatment strategies are rather empirical, not addressing the primary cause of the disease, which in many cases can result in treatment failure. 7, 13, 19, 31, 45 Even though CMI and IIH differ with regard to clinical presentation, radiological findings, and treatment, common underlying mechanisms have been proposed 6 based on observations that both CMI and IIH occur frequently in young, often obese women; 9, 24 that the 2 entities share similar symptoms; 19 and, most importantly, that some IIH patients present with radiological evidence of tonsillar ectopy. 1, 4, 40 In addition, some investigators have described patients diagnosed with CMI as having IIH-like symptoms and not responding to FMD. 19, 23, 39 However, current evidence in favor of a common pathophysiological mechanism in the 2 conditions is still weak and requires further analysis.
In this present study, we therefore wished to explore whether CMI and IIH share common pathophysiological mechanisms, as well as to verify the hypothesis that tonsillar ectopy, a typical finding in CMI, results from pathological intracranial pressure (ICP) combined with a developmentally small PCF. With improved understanding of the association between CMI and IIH, we hope to contribute to more optimal treatment strategies in these patients.
We specifically questioned whether pulsatile and static ICP are comparable and whether intracranial volumes (ICVs) are different in CMI and IIH; of particular interest, then, was the PCF volume (PCFV), which could explain the tonsillar ectopy in CMI. We also addressed whether the symptom profile is comparable in the 2 patient groups. For this purpose, we identified all CMI and IIH patients who had undergone continuous overnight diagnostic recording of static and pulsatile ICP in the Department of Neurosurgery, Oslo University Hospital-Rikshospitalet, during the period from 2002 to 2014. The symptom profile, radiological findings including measurements of ICV, and static and pulsatile ICP scores were compared between the CMI and IIH cohorts.
Methods

Ethics Approval
This study was approved by the Oslo University Hospital-Rikshospitalet as a quality control study. The Regional Committee for Medical and Health Research Ethics (REK) of Health Region South-East, Norway, was informed in writing and had no objections to the study. Intracranial pressure data were retrieved from the Neurovascular-Hydrocephalus Quality Register.
Patient Cohorts
We identified patients diagnosed with either CMI or IIH from the department's prospective database of ICP recordings performed in patients with various conditions related to disturbed CSF dynamics during the period from 2002 to 2014. We excluded all patients in whom ICP recording had been performed after a previous attempt at surgical treatment.
The CMI and IIH cohorts were compared with a reference (REF) group consisting of subjects who had undergone overnight diagnostic ICP recording for suspected idiopathic normal-pressure hydrocephalus or chronic daily headache, to rule out IIH without papilledema. None of the patients in the REF group had undergone surgical treatment, and their ICP scores were considered to be within normal thresholds.
Assessment of Clinical Symptoms and Findings
We retrieved information from the patients' electronic health records regarding clinical symptoms or findings as noted at the outpatient clinic and/or at admission prior to the initial diagnostic ICP recording. Treatment outcome was defined as a change in symptoms and/or findings at the latest follow-up and was divided into 2 main categories: responders (relief or improvement in symptoms and/ or findings) and nonresponders (unchanged or worsening symptoms and/or findings). However, it should be stressed that neither details on clinical treatment nor evaluation of outcome was the primary focus of this particular study.
Tonsillar Ectopy and ICV Measurements: MRI Assessment
We retrieved patients' MRI scans that had been obtained at the time of initial investigation, that is, prior to any treatment. The position of cerebellar tonsils caudal or cranial to the level of the foramen magnum was defined by the distance (mm) of the caudal tonsillar tip on a line perpendicular to a line between the basion and opisthion (that is, foramen magnum or McRae's line) on midsagittal MRI (Fig. 1) . A positive value of cerebellar ectopy means a distance caudal to McRae's line, while a negative value means a distance cranial to McRae's line. The presence of syringomyelia in CMI patients was noted. As neither CMI nor IIH patients usually have ventriculomegaly as defined by morphometric measures, we decided to measure relevant ICVs to compare these 2 cohorts. For this purpose, we used iPlan volumetric software incorporated into the neuronavigation tool (BrainLab AG). After the fusion of axial T2-weighted scans with sagittal T1-weighted scans and manually adjusted automatic delineation at 1-mm slice reconstruction, we measured the following volumes: ventricular CSF volume (VV), total ICV, and PCFV (Fig.  2) . From these, we calculated a ratio between VV and ICV (VV index) and between PCFV and ICV (PCF index).
Monitoring of Pulsatile and Static ICP Scores
Diagnostic ICP monitoring was performed using a solid ICP sensor (Codman MicroSensor, Johnson & Johnson) introduced 1-2 cm into the frontal brain parenchyma through a cranial bur hole under either local or occasionally general anesthesia (in children). The ICP recordings were stored as raw data files on the hospital server (sampling rate 100 or 200 Hz). We used the automatic algorithm for ICP analysis incorporated into the dedicated software (Sensometrics software, dPCom AS). This algorithm computes the mean ICP during 6-second time windows independent of the ICP waveform. The ICP waveform analysis uses an algorithm for identification of the cardiac beat-induced single pressure wave, determining the amplitude (that is, difference between beginning diastolic pressure and systolic pressure) and the latency (that is, time interval from beginning diastolic pressure to systolic pressure) of the single ICP waves and then computing the pressure parameters during subsequent 6-second time windows. Using this waveform algorithm, we determined the quality of the ICP recordings as a percentage of the 6-second time windows accepted for analysis, while the others were rejected because of artifacts in the ICP signal.
For every ICP trend plot, we computed the average values of 1) mean ICP (averaged ICP over the 6-second time window, representing the static ICP), 2) MWA (averaged ICP pulse amplitude [dP] over the 6-second time window, representing the pulsatile ICP); 3) MWRT (averaged pulse rise time [dT] over the 6-second time window); and 4) MWRT coefficient (MWRTC; averaged pulse rise time coefficient [dP/dT] over the 6-second time window).
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The pulsatile ICP was tentatively considered elevated when the average MWA was higher than 4 mm Hg combined with an MWA higher than 5 mm Hg in more than 10% of the recording time. 13, 15 Elevated static ICP was defined as mean ICP higher than 15 mm Hg.
Statistical Analysis
All statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) software, version 22.0 (IBM Corp.). The statistical significance of the differences between the cohorts was accepted at the 0.05 level.
Results
Patient Cohorts
Sixty-six patients with CMI and 41 with IIH were in- cluded in the study. The REF group consisted of 41 patients under 60 years of age with suspected normal-pressure hydrocephalus (30 patients) or chronic daily headache (11 patients), in whom elevated ICP was clinically suspected but not confirmed by ICP recording. Table 1 summarizes the demographic and clinical characteristics of both patient cohorts and the REF group. The 2 patient cohorts were equal in terms of mean age and exhibited only slight differences in female predominance and body mass index (BMI). Table 2 indicates a slightly different profile of symptoms in the CMI and IIH cohorts. Some symptoms were recorded in both groups; of those, headache was the most dominant symptom with almost equal occurrence in the 2 groups, followed by nausea and/or vomiting, which affected approximately one-third of the patients in each group. All of these symptoms were significantly more frequent than in the REF group. Dizziness and gait ataxia occurred significantly more often in CMI patients, whereas visual symptoms or phenomena, diplopia, and tinnitus were significantly more frequent in IIH patients.
Clinical Symptoms and Findings in the CMI and IIH Cohorts
Of those symptoms specifically observed in only 1 of the patient cohorts, neck pain and sensory symptoms from the extremities dominated among CMI patients, whereas papilledema was the most prominent finding specific to IIH patients. Of those symptoms observed in less than 10% of CMI patients, we noticed dysarthria in 5 patients (7.6%), temperature dysesthesia in the extremities and facial numbness each in 3 patients (4.5%), palpitations and muscle pain or seizures each in 2 patients (3.0%), and uvula or tongue deviation, urinary incontinence, and apnea each in 1 patient (1.5%). In the IIH group each of the following symptoms or signs was observed in 1 patient (2.4%): abdominal pain, absence seizures, delayed development, macrocrania, failure to thrive, and nasal CSF leakage.
With regard to surgical treatment (Table 1) , 23 (35%) of the 66 CMI patients underwent a CSF diversional procedure (that is, shunt placement) either as a stand-alone treatment (4 patients) or in addition to FMD (19 patients). Of the 19 CMI patients treated with both FMD and CSF shunt, 12 had received the shunt first based on initial diagnostic ICP recording. The other 7 CMI patients received the CSF shunt some time (3 days-20 months) after the FMD because of persistent symptoms of elevated (pulsatile) ICP, often documented by a new ICP recording. Follow-up data were only available for 62 of the 66 CMI patients and 39 of the 41 IIH patients.
Tonsillar Ectopy and Cranial Volume Measures: MRI Findings
As expected, the extent of tonsillar ectopy was significantly different between the CMI and IIH cohorts. The mean extent of ectopy of the cerebellar tonsils was 12.6 mm under the level of the foramen magnum in the CMI cohort, whereas tonsils laid a mean 1.7 mm above the foramen magnum line in the IIH cohort (Table 3) . Notably, 3 (7.3%) of 41 IIH patients had tonsillar ectopy qualifying for a diagnosis of CMI (that is, > 5 mm). The position of the cerebellar tonsils was significantly lower in both the CMI and IIH cohorts than in the REF group (Fig. 3) .
We found no differences in the cranial volume measurements (VV, ICV, PCFV, or the VV as well as the PCF 
Pulsatile and Static ICP Scores in the CMI and IIH Cohorts
The pulsatile ICP scores were comparable in the CMI and IIH cohorts and were significantly elevated in both cohorts as compared with the REF group (Table 4) . On the other hand, the static ICP (mean ICP) was significantly higher (p < 0.001) in the IIH than in the CMI cohort and the REF group. Figure 4 shows comparisons of the distribution of the pulsatile and static ICP scores between the CMI and IIH cohorts as well as the REF group.
Association Between ICP Measures and MRI Findings
As presented in Table 5 , there was a significant positive correlation between mean ICP or MWA (that is, static and pulsatile ICP) and VV or VV index in the CMI cohort. In addition, there was a significant negative correlation between mean ICP and PCFV index, whereas this association was only close to significant for MWA. On the other hand, there was no significant correlation between the static or pulsatile ICP scores and ICV or PCFV, nor any significant association with the extent of tonsillar ectopy.
No significant association between ICP parameters and MRI findings was observed in the IIH cohort. In the REF group, there was a significant positive correlation between the extent of tonsillar ectopy and MWA.
Discussion
The main finding in the present study is the comparable and elevated pulsatile ICP, indicative of impaired intracranial compliance, in both CMI and IIH patients. We found no evidence of associated reduced ICV or PCFV as a possible cause of tonsillar ectopy in the CMI patients. To our knowledge, this is the first study to systematically compare clinical, radiological, and ICP data from patients with CMI and IIH.
Patient Cohorts
Our cohorts of CMI and IIH patients were comparable regarding sex distribution and age. Most patients were young adults, predominantly females, with a slightly higher BMI in the IIH cohort as expected since being overweight is a characteristic feature of IIH patients. 3, 24, 44 The scope of this work was not to evaluate the outcome of treatment in detail. Nonetheless, we noticed high rates of responders to treatment in both patient cohorts. More patients in the CMI group were selected for conservative treatment. This difference may be due to a usually more severe clinical presentation in IIH, requiring prompt treatment. At the same time, both CMI and IIH patients in the present study were those selected for diagnostic ICP recording, that is, symptomatic patients who were considered candidates for treatment; thus, they may not represent the CMI or IIH populations in general.
Clinical Presentation in CMI and IIH
Analysis of the symptom profile in our cohorts of CMI and IIH patients revealed some similarities, while both groups naturally had specific features. The occurrence of headache and nausea and/or vomiting was comparable between the 2 cohorts. Although these symptoms may be indicative of alterations in ICP and thus reflect the impaired intracranial compliance, this association is not specific and there may be alternative causes. On the other hand, the frequency of these symptoms in the 2 patient cohorts was significantly higher than in the REF group. Some of the specific symptoms characterizing the CMI cohort were probably related to tonsillar ectopy into the foramen magnum. The resulting compression of long neural tracts may also explain gait ataxia, which was observed more frequently in the CMI cohort.
The high prevalence of visual disturbances, diplopia, and papilledema in the IIH group could be expected as these are characteristic findings for the condition. 22 Papilledema is typical for IIH but rare in CMI. However, it has also been reported that bilateral papilledema, as well as signs and symptoms of increased ICP, resolve after FMD in patients with IIH and documented tonsillar ectopy. 37, 43, 46 Previously, several studies, most of which were case reports, pointed to the similarities in clinical presentation between CMI and IIH. 23, 26, 27, 30, 39, 40 Fagan et al. 19 reported that 36 of 192 CMI patients did not respond with clinical improvement after FMD. Among these nonresponders, 15 (41.7%) had "Chiari pseudotumor cerebri syndrome," defined by the recurrence of Chiari-like symptoms after FMD, elevated lumbar CSF pressure in the absence of ventriculomegaly, and transient resolution of symptoms with a large volume of lumbar CSF drainage. The most frequent symptoms in this subgroup were headache, body aches, and balance difficulties. Interestingly, 7 of 9 pediatric patients responded to treatment (CSF diversion), while all 6 adult patients remained variably symptomatic. Moreover, Bejjani et al., 7 after failed FMD, successfully treated their 6 CMI patients with CSF diversion, and they mentioned initially misdiagnosed IIH as one of the possible explanations. In the study by Zakaria et al., 45 12 (8.7%) of 138 CMI patients still had clinical and/or radiological signs of increased ICP after FMD, 9 (6.5%) of them requiring treatment. These authors interpreted the postoperative rise in ICP as a manifestation of a fundamental underlying change in CSF flow dynamics following FMD but did not specifically mention any possible association with IIH.
However, observations that some symptoms occur in both CMI and IIH patients and that some CMI patients respond to shunting rather than to FMD cannot alone be taken as proof that these conditions share common underlying pathophysiology.
Radiological Findings and ICV Measurements in CMI and IIH
Significant tonsillar ectopy can be found in some IIH patients. The incidence of asymptomatic tonsillar ectopy (≥ 5 mm) was previously found to be 0.8% of 22,591 patients who had undergone MRI. 32 In our study, 7.3% of IIH patients had tonsillar ectopy, actually qualifying them for a diagnosis of CMI. This is not far from the 10.3% found by Banik et al. 4 but is much less than the rate in the radiological study by Aiken et al., 1 who found ectopy > 5 mm in 20.9% of IIH patients compared with 2.3% of controls. In this latter study, IIH patients also had a significantly lower tonsillar position (mean 2.1 ± 2.8 mm) than that in agematched controls. 1 This was similar to our own finding that the position of the cerebellar tonsils was significantly lower in both CMI and IIH cohorts than in the REF group. This observation suggests that tonsillar ectopy may be an epiphenomenon to elevated pulsatile ICP and impaired intracranial compliance. On the other hand, all 3 of our IIH patients with tonsillar ectopy > 5 mm had papilledema and responded to treatment with a CSF shunt; that is, they could be clinically considered as typical IIH patients with only coincidental asymptomatic tonsillar ectopy.
We found no evidence of differences in VV, ICV, and PCFV between the CMI and IIH cohorts. The significance of this finding is discussed below in association with ICP scores. The significantly higher VV and VV index in the REF group were due to a higher percentage of patients with ventriculomegaly in this group, which was usually also the reason for their referral to diagnostic ICP recording.
Pulsatile and Static ICP in CMI and IIH
The present study showed comparable and elevated pulsatile ICP in both CMI and IIH patients, which supports our previous observations in these 2 patient groups. 13, 20 Pulsatile ICP appears to be a better indicator of the pressure-volume reserve capacity (that is, the intracranial compliance) than static ICP.
11 Accordingly, we interpret our observations of elevated pulsatile ICP in both patient cohorts as evidence that impaired intracranial compliance is a common pathophysiological mechanism behind both conditions. However, this is not proof of an etiological association between CMI and IIH as we previously have reported elevated pulsatile ICP and hence impaired intracranial compliance in patients with normal-pressure hydrocephalus 15 and following intracranial bleeds. 14 Intracranial compliance can also be principally affected by a number of other pathological conditions of the brain.
Notably, the IIH patients had significantly higher static ICP. This fact may be associated with a poorer quality of ICP recording in this group as static ICP may be subject to baseline pressure errors. 16, 17 On the other hand, the elevated static ICP may indicate more severe intracranial hypertension in the IIH cohort than in the CMI cohort. In previous studies, mean ICP was found to be abnormal (that is, > 15 mm Hg) in 50% of IIH patients 13 but in none of the CMI patients. 
Intracranial Volume Measurements Versus ICP Scores in CMI and IIH
Another part of the hypothesis of a common underlying pathophysiology in CMI and IIH is the assumption that elevated ICP combined with reduced ICV and/or PCFV causes the features characteristic of CMI, particularly the tonsillar ectopy. However, one may question why only CMI patients present with tonsillar ectopy and syringomyelia if both CMI and IIH share a common pathophysiological background, while IIH patients only inconsistently exhibit some specific radiological features (empty sella, flattening of the posterior aspect of the ocular globe, distension of the perioptic subarachnoid space with or without a tortuous optic nerve, and transverse venous sinus stenosis), though unconditional for diagnosis. 22 Bejjani 6 suggested a common pathophysiology in the form of "craniocephalic disproportion" in which disproportion between the skull and brain can lead to CMI (due to a small skull or PCF) and/or IIH (due to an "engorged" brain), which in addition will occasionally lead to tonsillar ectopy.
The role of reduced PCFV in the pathophysiology of CMI has been widely debated and documented by many authors.
2,10,34 Milhorat et al. 34 even recommended the measurement of PCFV as a guide to clinical management and distinguished typical CMI with reduced PCFV from CMI with normal PCFV in which alternative mechanisms of tonsillar herniation should be investigated, raised ICP among them.
However, as recently emphasized by Roller et al., 38 age, race, sex, and BMI each statistically significantly influence PCFV as well as total ICV. These authors could not find any statistically significant differences in PCFV, ICV, or the ratio between these volumes when comparing the CMI and control group after controlling for demographics, whereas patients with IIH were more likely to have a smaller PCFV and larger ICV. From our own measurements, we could conclude that there was no significant difference between the CMI and IIH cohorts in terms of VV, PCFV, and ICV. Our ICV and PCFV values correlate very well with those found by Alperin et al. 2 in CMI patients, whose PCFV (184 ± 19 vs 211 ± 16 ml, p < 0.001) as well as PCF index (12.4% ± 0.8 vs 14% ± 0.8, p < 0.001) was significantly smaller than that in controls. From this indirect comparison, we can therefore speculate that PCFV is probably smaller in both CMI and IIH patients, although compared with our own REF group, no significant difference in PCFV was found. However, this issue appears irrelevant as there was no significant statistical correlation between PFCV and static and/or pulsatile ICP in either of our 2 cohorts.
Taken together, our findings suggest that intracranial compliance is impaired in both CMI and IIH, but they do not explain why some of the patients presented with tonsillar ectopy and/or syringomyelia (that is, CMI) while others presented with visual symptoms, papilledema, and high static ICP (that is, IIH).
In the clinical setting, this possible association between CMI and IIH is particularly important to keep in mind for CMI patients. In cases lacking a response to treatment (FMD) with symptoms indicative of persistent elevated ICP, surgical CSF diversion (that is, a shunt) must be strongly considered. Accordingly, we believe that data from the present study and the relevant literature justify the routine use of diagnostic ICP recording with analysis of the pulsatile ICP in symptomatic CMI patients who are considered candidates for surgical treatment. For the patients diagnosed with IIH, significant tonsillar ectopy must be ruled out by MRI prior to any diagnostic and/or therapeutic lumbar puncture with tapping of the CSF. As elevated static ICP appears to be a specific finding for the IIH group, it may be a certain clinical indicator of the need for CSF diversion in cases of diagnostic doubt between CMI and IIH.
Conclusions
This study shows comparable and elevated pulsatile ICP, indicative of impaired intracranial compliance, in both CMI and IIH patients, whereas static ICP is higher in IIH patients. The present data do not support the hypothesis that reduced PCFV combined with increased ICP causes tonsillar ectopy in CMI. Even though impaired intracranial compliance seems to be a common pathophysiological mechanism behind both conditions, mechanisms explaining the different clinical presentations of CMI and IIH remain undefined. 
